Speaker

Dr. Sangeeta N. Bhatia conducts research at the intersection of engineering, medicine, and biology to develop novel platforms for understanding, diagnosing, and treating human disease. Her ‘tiny technologies’ interface living cells with synthetic systems for medical applications. Dr. Bhatia’s findings have produced high-throughput-capable human microlivers, which model human drug metabolism, drug-induced liver disease, and interaction with human pathogens. Her group also develops nanoparticles and nanoporous materials that can be designed to assemble and communicate to diagnose and treat a variety of diseases, including cancer.

Dr. Bhatia directs the Laboratory for Multiscale Regenerative Technologies at MIT. She is a Howard Hughes Medical Institute Investigator and the John J. and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science at MIT. She is a member of the Koch Institute for Integrative Cancer Research, a senior member of the Broad Institute, and a biomedical engineer at Brigham & Women’s Hospital. Dr. Bhatia is a fellow of the American Institute for Medical and Biological Engineering, the Biomedical Engineering Society, and the American Society for Clinical Investigation. She has been awarded the 2014 Lemelson-MIT Prize, the David and Lucile Packard Fellowship given to “the nation’s most promising young professors in science and engineering,” the NSF CAREER Award, the Harvard Medical School Diversity Award, and the Harvard-MIT Thomas McMahon Mentoring Award, among many others.

Dr. Bhatia co-authored the first undergraduate textbook on tissue engineering and has published more than 150 manuscripts that have been cited over 13,500 times. She and her 150+ trainees have contributed to more than 40 issued or pending patents and launched 9 biotechnology companies with close to 75 products. She is a frequent advisor to governmental organizations, industrial corporations, and think tanks. Dr. Bhatia holds a B.S. from Brown University; M.S. and Ph.D. degrees from MIT; and an M.D. from Harvard Medical School.